SunWay Biotech Co., Ltd.(TW:1271)
NT$58.80+0.80 (+1.38%)
TW:1271
SunWay Biotech Co., Ltd. financials statements
NT$58.80
At close:+0.80 (+1.38%)
SunWay Biotech Co., Ltd. (1271) Income Statement
SunWay Biotech Co., Ltd. Income Statement
Last quarter (Q2 2026), SunWay Biotech Co., Ltd.'s total revenue was NT$1.01B, an increase of 108.31% from the same quarter last year. In Q2, SunWay Biotech Co., Ltd.'s net income was NT$79.28M. See SunWay Biotech Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 993.30M | NT$ 970.18M | NT$ 571.11M | NT$ 425.35M | NT$ 380.43M | |
| NT$ 560.50M | NT$ 545.04M | NT$ 236.91M | NT$ 149.89M | NT$ 271.11M | |
| NT$ 456.37M | NT$ 404.06M | NT$ 183.61M | NT$ 111.03M | NT$ 103.37M | |
| Depreciation and Amortization | NT$ 70.76M | NT$ 83.59M | NT$ 24.91M | NT$ 7.76M | NT$ 19.73M |
| NT$ 197.44M | NT$ 231.26M | NT$ 83.22M | NT$ 48.54M | NT$ 190.47M | |
| NT$ 104.13M | NT$ 140.98M | NT$ 52.44M | NT$ 39.23M | NT$ 167.74M | |
| NT$ 11.29M | NT$ 1.11M | NT$ 3.79M | NT$ 400.00K | NT$ 2.91M | |
| NT$ 115.42M | NT$ 142.09M | NT$ 56.23M | NT$ 39.63M | NT$ 170.21M | |
| NT$ 101.49M | NT$ 118.57M | NT$ 46.09M | NT$ 30.04M | NT$ 168.76M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.68 | NT$ 1.96 | NT$ 1.51 | NT$ 1.49 | NT$ 5.02 |
| Diluted EPS | NT$ 1.68 | NT$ 1.96 | NT$ 1.50 | NT$ 1.48 | NT$ 4.92 |
| Weighted Average Shares Outstanding | 60.41M | 60.39M | 30.58M | 20.15M | 33.75M |
| Weighted Average Shares Outstanding (Diluted) | 60.41M | 60.44M | 30.64M | 20.22M | 34.35M |
Currency in TWD
